Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004497200 on July 25, 2000

J. Biol. Chem., Vol. 275, Issue 41, 32277-32280, October 13, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/41/32277    most recent
M004497200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birch, O. M.
Right arrow Articles by Shaw, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birch, O. M.
Right arrow Articles by Shaw, N. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

MioC Is an FMN-binding Protein That Is Essential for Escherichia coli Biotin Synthase Activity in Vitro*

Olwen M. BirchDagger , Kirsty S. Hewitson§, Martin FuhrmannDagger , Knut BurgdorfDagger , Jack E. Baldwin§, Peter L. Roach||**, and Nicholas M. ShawDagger DaggerDagger

From the Dagger  Biotechnology Research, Lonza A.G., CH-3930 Visp, Switzerland, § Dyson Perrins Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QY, United Kingdom, and the || Department of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, United Kingdom

Received for publication, May 24, 2000, and in revised form, July 10, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Biotin synthase is required for the conversion of dethiobiotin to biotin and requires a number of accessory proteins and small molecule cofactors for activity in vitro. We have previously identified two of these proteins as flavodoxin and ferredoxin (flavodoxin) NADP+ reductase. We now report the identification of MioC as a third essential protein, together with its cloning, purification, and characterization. Purified MioC has a UV-visible spectrum characteristic of a flavoprotein and contains flavin mononucleotide. The presence of flavin mononucleotide and the primary sequence similarity to flavodoxin suggest that MioC may function as an electron transport protein. The role of MioC in the biotin synthase reaction is discussed, and the structure and function of MioC is compared with that of flavodoxin.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Biotin synthase (BioB) catalyzes the final step of the biotin biosynthetic pathway, where a sulfur atom is inserted between the unactivated methyl and C-6 methylene carbon atoms of dethiobiotin (1) (Fig. 1). Catalytic activity has not yet been consistently observed for this reaction in vitro (2-4). The activity measured in vitro requires a complex mixture of small molecules and accessory proteins (3, 5-7). Cysteine is the initial source of the sulfur atom for the reaction, and Fe2+, dithiothreitol, NADPH, S-adenosylmethionine, and one of the amino acids asparagine, aspartate, glutamine, or serine are required (7). At least three other proteins are required for biotin synthase activity. Two have been identified as flavodoxin and ferredoxin (flavodoxin) NADP+ reductase (6, 7, 9). These proteins are thought to provide an electron transfer pathway from NADPH to the Fe-S cluster1 of biotin synthase. The reduced Fe-S cluster has been proposed to reductively cleave S-adenosylmethionine to give methionine and a 5'-deoxyadenosyl radical (7, 10). Evidence from experiments with deuterium-labeled dethiobiotin suggests that the 5'-deoxyadenosyl radical abstracts a hydrogen atom directly from dethiobiotin (11). Two recent reports demonstrated that the Fe-S cluster of biotin synthase also serves as the immediate sulfur donor for the dethiobiotin to biotin conversion (4, 12). The Fe-S cluster of biotin synthase may therefore have a dual function, and Fe-S cluster forming proteins, such as IscS, IscU and IscA, may thus be required for catalytic activity (13-15). However, the mechanism of Fe-S cluster formation in vivo remains unknown.


View larger version (5K):
[in this window]
[in a new window]
 
Fig. 1.   The conversion of dethiobiotin to biotin.

A third protein required for biotin synthase activity in vitro has previously been reported (6, 7) but not identified. This protein eluted from a Q-Sepharose column at a NaCl concentration of ~0.5 M and required TPP to stabilize its activity during purification. We have now purified this protein, obtained a N-terminal amino acid sequence and identified it as MioC. In this paper we also report the cloning, overexpression, and characterization of MioC.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chemicals-- All chemicals were of reagent grade and unless otherwise stated were obtained from either Sigma or Fluka. Restriction enzymes and molecular biology reagents were from Promega, and oligonucleotides were from Genosys. [14C]Dethiobiotin (57.2 mCi/mmol) was custom synthesized by Isotopchem (Ganagobie, France). Recombinant flavodoxin was purified from Escherichia coli (16).

Initial Purification and Sequencing of MioC-- MioC was first purified from an extract of E. coli BM4062 that contained the plasmid pBO30A-15/9 (see Ref. 7 for details of bacterial strains, plasmids, cell growth, and preparation of extracts). The amino acid sequence was determined with a model 477A Microsequencer (Applied Biosystems) after cutting the protein band from a polyvinylidene difluoride membrane (from blotting an SDS-PAGE gel) stained with Amido Black (17).

Cloning, Overexpression, and Purification of MioC-- Standard methods for the manipulation of DNA were used (18). MioC was initially cloned from an E. coli Kohara gene bank. The mioC gene was identified by hybridization against a specific oligonucleotide formulated from the mioC DNA sequence (19) and then cloned to form plasmid pMO4-1. The mioC gene was then amplified by polymerase chain reaction from pMO4-1 and ligated into the pGEM-T vector. The primers used were: forward, 5'-CCATGGCAGATATCACTCTTATCAGCGGC-3'; reverse, 5'-GGATCCTTATTTGAGTAAATTAACCCACGATCCC-3'. A 0.4-kilobase fragment encoding the mioC gene was then excised from the pGEM-T vector with NcoI and BamHI and subcloned into the pET 24d(+) vector (Novagen) to generate an expression vector for MioC, pMIO.

E. coli BL21(DE3) cells were transformed with pMIO and grown at 37 °C in 2TY medium containing 30 µg/ml kanamycin. When the attenuance at 600 nm (D600) reached 1.0, isopropyl-beta -D-thiogalactoside was added to a final concentration of 0.1 mM. After 2.5 h the cells were harvested by centrifugation at 4 °C and stored at -80 °C.

Purification of MioC was carried out at 4 °C. Frozen cells containing pMIO (~100 g of wet weight) were thawed and resuspended in 300 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 1 mM dithiothreitol. Chicken egg white lysozyme was added (0.5 mg/ml), the mixture was stirred for 15 min, and Triton X-100 was added to 1.0% (w/v). After a further 15 min, the cell debris was removed by centrifugation for 30 min at 15,000 × g. The resulting cell-free supernatant was loaded onto a 285.0 ml Q-Sepharose HP column that had been equilibrated with 50 mM Tris-HCl buffer, pH 7.5 (buffer A). Proteins were eluted with a linear gradient of NaCl from 0 to 600 mM in buffer A over 10 column volumes. Fractions containing MioC were concentrated to 50 mg/ml, and 7 ml was loaded onto a 700-ml column of Superdex 75 that had been equilibrated with buffer A. Proteins were eluted isocratically with the same buffer. The purest MioC containing fractions (>95% as judged by SDS-PAGE), were combined, concentrated to ~40 mg/ml, and stored at -80 °C.

Measurement of Biotin Synthase Activity in Vitro-- To assay biotin synthase activity in vitro and the involvement of MioC, the incorporation of radioactive label from [14C]dethiobiotin into biotin was measured in the presence of biotin synthase and protein fractions. The assay was as follows (7): enriched fractions of biotin synthase and ferredoxin (flavodoxin) NADP+ reductase and pure flavodoxin were incubated in a final volume of 250 µl at pH 7.5 with Fe2+-gluconate (50 nmol), NADPH (25 nmol), thiamine pyrophosphate (25 nmol), S-adenosylmethionine (23 nmol), asparagine (3.75 µmol), dithiothreitol (250 nmol), Hepes buffer (25 µmol), and [14C]dethiobiotin (0.1 µCi, 1.95 nmol) plus cysteine (83 nmol). After incubation at 37 °C for 1 h, the reaction was stopped by the addition of 250 µl of 12.5% (w/v) trichloroacetic acid. [14C]Dethiobiotin and [14C]biotin were then purified before analysis by TLC or HPLC (7).

Spectroscopic Studies-- UV-visible absorption spectra were measured over the scan range 300-800 nm using a Shimadzu UV-1601 spectrophotometer at protein concentrations of 0.5 mg/ml in 50 mM Tris-HCl buffer, pH 7.5. Electrospray ionization mass spectra were recorded on a Micromass BioQ II-ZS triple quadrupole mass spectrometer. Samples (10 µl) were introduced into the electrospray source via a loop injector as a solution with a final protein concentration of 5 pmol/µl in water:acetonitrile (1:1 v/v) containing 0.2% formic acid. Spectra of the MioC flavin cofactor were recorded under negative ion conditions over the scan range 418-618 Da.

Flavin Analysis-- A Waters HPLC system fitted with an ODS Hypersil column (250 × 4.6 mm) and a Jasco FP-920 intelligent fluorescence detector were used for these experiments. The column was calibrated with FMN and FAD standards (10- and 30-µl injections of solutions with a concentration of 0.1 mg/ml). The mobile phase was acetonitrile/water/trifluoroacetic acid (10.0% (w/v) in water)/phosphoric acid (14:84:1.5:0.09), and the flow rate was 0.5 ml/min. The excitation wavelength for the fluorescence detector was 430 nm, and the emission wavelength was 525 nm. Purified MioC was mixed with a solution of 5.0% (w/v) trichloroacetic acid in water, and the precipitated protein was removed by centrifugation at room temperature. The resulting supernatant was injected onto the column, and the results were compared with those from the standard samples of FMN and FAD.

Molecular Mass Determination-- The apparent molecular mass of MioC was determined using a Superdex 200 HR 10/30 column equilibrated with 100 mM Tris-HCl, pH 7.5, and with a range of NaCl concentrations (0.25, 1.0, and 2.0 M) at a flow rate of 0.5 ml/min. The column was calibrated with ribonuclease A (13.7 kDa), chymotrypsinogen A (25 kDa), ovalbumin (43 kDa), and bovine serum albumin (67 kDa) (Gel Filtration Calibration Kit; Amersham Pharmacia Biotech). An elution volume parameter (Kav) was calculated for each of the calibration proteins at the various salt concentrations, and a calibration curve was constructed. By calculating Kav for MioC and flavodoxin, the native molecular masses of these proteins were established.

Gel Electrophoresis-- Both SDS-PAGE (15.0%) and native gel (20.0%) electrophoresis were performed using standard techniques with a Bio-Rad Mini Protean II kit. SDS-PAGE (10-15%) was also carried out with the Phast System from Amersham Pharmacia Biotech.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Evidence That the MioC Protein Is Required for Biotin Synthase Activity in Vitro-- We have shown previously that a number of low molecular weight compounds plus at least flavodoxin, ferredoxin (flavodoxin) NADP+ reductase, and a third protein are essential for biotin synthase activity in vitro (6, 7). We have now identified the third essential protein as MioC, which we purified on the basis of its activity in a biotin synthase assay (7). When partially purified biotin synthase, flavodoxin, and ferredoxin (flavodoxin) NADP+ reductase fractions prepared by ion exchange chromatography on a Q Sepharose Fast Flow column plus the essential low molecular weight compounds were incubated with dethiobiotin, no biotin was formed. Addition of MioC, either as a partially purified fraction or as the purified protein (Fig. 2), resulted in the formation of biotin (Fig. 3).


View larger version (108K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-PAGE of MioC purified on the basis of its activity in the biotin synthase reaction. Silver-stained 10-15% SDS-PAGE gel (Phast system; Amersham Pharmacia Biotech) showing fractions 25 from the final Mono Q column. An unstained SDS-PAGE gel similar to this (normal format) was blotted onto a polyvinylidene difluoride membrane and stained with Amido Black. The protein band was cut out and sequenced. Lane 25 contains fraction 25 from the Mono Q column. The far-right lane contains molecular mass markers (Amersham Pharmacia Biotech): 14.4, 20.1, 30.0, 45.0, 66.0, and 97.0 kDa.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   MioC is required for biotin synthase activity in vitro. Biotin synthase activity was measured by the conversion of [14C]dethiobiotin to [14C]biotin. Substrate and product were separated by TLC and detected by autoradiography. Lane 1, biotin standard; lane 2, assay containing all standard components except for a fraction containing MioC; lane 3, assay containing all standard components plus the preparation of MioC from the first Q Sepharose Fast Flow chromatography column (7); lane 5, assay containing all standard components plus fraction 25 from the final Mono Q column (see Fig. 2).

We initially purified MioC, based on its activity in the biotin synthase reaction, from 36.0 g of cells using a multi-step chromatographic procedure (Q Sepharose Fast-Flow, HiLoad Q Sepharose HP, Sephacryl S-100 HR, HiLoad 26/10 Phenyl Sepharose HP, Phenyl Superose HR5/5, heat treatment at 100 °C for 3 min, and further chromatography on Sepharose Blue Hi-Trap and Mono Q HR 5/5; details of this purification are not given, because a more elegant purification scheme was designed after the protein was identified and cloned: see "Materials and Methods") and obtained one fraction that contained pure MioC (fraction 25) as judged by SDS-PAGE analysis with silver staining (Fig. 2). Protein from a gel similar to that shown in Fig. 2 was blotted onto a polyvinylidene difluoride membrane, and the band at ~14 kDa was sequenced. The amino acid sequence was Ala-Asp-Ile-Thr-Leu-Ile-Ser-Gly-Ser-Thr, which corresponded to amino acids 2-11 of E. coli MioC.

Activity in the in vitro biotin synthase assay described above was observed when fraction 25, which contained MioC, was included (Fig. 3). Although MioC was essential for biotin synthase activity in vitro, we calculated that the catalytic center activity of the enzyme was less than 1. This is consistent with our earlier results and those from other groups (2, 3, 4, 7). MioC alone could not replace either the flavodoxin or the ferredoxin (flavodoxin) NADP+ reductase fractions, or both, in the assay.

Overexpression and Purification of MioC-- Expression of MioC to ~15% of the total soluble protein, as judged by SDS-PAGE analysis, was achieved by the use of plasmid pMIO. Development of an efficient expression system allowed the purification to be simplified to a two-column procedure that yielded relatively large quantities of protein, typically 200 mg from 100 g of cells (see "Materials and Methods"). The initial chromatography step in the purification was a Q Sepharose column. Analysis of the fractions by SDS-PAGE revealed that MioC eluted in two peaks. The first peak was colorless and was assumed to be the apoprotein. This was confirmed by amino acid sequencing. The second peak was bright yellow, which was consistent with the protein containing the bound cofactor. The holoprotein represented approximately 25% of the total MioC protein. The presence of the apoprotein was attributed to the high expression level of MioC, with insufficient cofactor being biosynthesized or present in the growth medium. A similar effect was not, however, observed for flavodoxin, where the soluble expression levels were comparable with those of MioC.

Identification of the Flavin Cofactor in MioC-- The UV-visible absorption spectrum of MioC was characteristic of a flavoprotein, with absorbance maxima at 373.5 and 446.5 nm (Fig. 4). From this spectrum it was not possible to discriminate between FMN and FAD. However, electrospray ionization mass spectrometry of MioC under negative ion conditions showed a peak at 455.24 Da (Fig. 5). The calculated mass of FMN is 456.3 Da, and that of FAD is 783.5 Da, so the spectrum was consistent with FMN being the flavin cofactor bound to MioC.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4.   UV-visible spectrum of holo-MioC.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5.   Electrospray ionization mass spectrometry of MioC. The low molecular weight region shows a peak with a mass corresponding to that of FMN.

Denaturation, by the addition of 5.0% trichloroacetic acid to MioC, permitted the flavin cofactor to be released from the protein, indicating that the flavin was noncovalently bound to the enzyme. FAD and FMN standards could be separated by HPLC with retention times of 11.89 and 14.47 min, respectively. The supernatant from the MioC extraction gave a retention time of 14.52 min, again confirming FMN as the flavin cofactor.

Molecular Mass Determination-- The subunit molecular mass of MioC predicted from the DNA sequence is 15,676 Da. Gel filtration chromatography indicated that the apparent native molecular mass of MioC was 31,500 Da when 100 mM Tris-HCl, pH 7.5, was used as the running buffer, which may be explained if MioC exists as a dimer under these conditions. The gel filtration experiments were repeated together with flavodoxin, whose subunit molecular mass is 19,606 Da and with a range of NaCl concentrations in the running buffers. As the NaCl concentration was increased, both MioC and flavodoxin eluted later from the column. At 1.0 M NaCl the elution volume corresponded approximately to that of the monomer for both proteins (Table I). The apo form of MioC behaved as for the holoenzyme. The elution volumes of MioC and flavodoxin were not further affected when 2.0 M NaCl was added to the running buffer.

                              
View this table:
[in this window]
[in a new window]
 
Table I
The change in the molecular masses of MioC and flavodoxin after varying the NaCl concentration during gel filtration chromatography

On native gel electrophoresis MioC ran with a lower apparent molecular mass than trypsin inhibitor (20.1 kDa) and alpha -lactalbumin (14.4 kDa) standards and with a lower apparent molecular mass than expected for the monomer (Fig. 6). This may be due to the low pI value of MioC (the calculated pI for the MioC protein sequence is 4.3), or MioC may be tightly folded.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 6.   Native PAGE of MioC. Lane 1, trypsin inhibitor (20.1 kDa); lane 2, alpha -lactalbumin (14.4 kDa); lane 3, MioC (15.7 kDa).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Biotin synthase, anaerobic ribonucleotide reductase activating enzyme (AE), and pyruvate formate lyase AE all utilize flavodoxin, ferredoxin (flavodoxin) NADP+ reductase, NADPH, and S-adenosylmethionine and contain an Fe-S cluster. In contrast to biotin synthase, the 5'-deoxyadenosyl radical formed by the reductive cleavage of S-adenosylmethionine by pyruvate formate lyase AE and anaerobic ribonucleotide reductase AE abstracts a hydrogen atom to give a protein-based radical, which then reacts with the substrate (20, 21). The requirement for further additional proteins for activity also distinguishes biotin synthase from the pyruvate formate lyase and anaerobic ribonucleotide reductase enzyme systems. Unlike biotin synthase, both anaerobic ribonucleotide reductase AE and pyruvate formate lyase AE are catalytic in vitro and have fully defined assay systems.

The mioC gene is located next to oriC on the E. coli chromosome and although several investigations have tried to establish a role for mioC transcription in chromosome replication (22-24), the results were inconclusive (25, 26). To date, no function for MioC has been established. We have now shown that MioC is essential for E. coli biotin synthase activity in vitro.

When highly purified biotin synthase was incubated with photo-reduced deazaflavin in the absence of any other proteins, it was active (27). This suggests that photo-reduced deazaflavin can replace both the NADPH, flavodoxin, and ferredoxin (flavodoxin) NADP+ reductase electron transport system and MioC. In addition, sequence comparison studies predicted that MioC had a similar structure to flavodoxin and a flavin-binding motif (28), and we have provided experimental evidence that it binds FMN. Based on these observations, we propose that MioC is part of the electron transport system for biotin synthase. Our results can most easily be explained by MioC transferring electrons from flavodoxin to the Fe-S cluster of biotin synthase. Although the NADPH right-arrow ferredoxin (flavodoxin) NADP+ reductase right-arrow flavodoxin electron transport pathway has recently been verified by redox potentiometry (8), the reduction potential of the Fe-S cluster of biotin synthase remains unknown, and hence the final electron transfer step from flavodoxin to biotin synthase has not been confirmed.

Biotin synthase has not yet been shown to catalyze the conversion of dethiobiotin to biotin in vitro. The Fe-S cluster of biotin synthase provides the sulfur atom for the dethiobiotin to biotin conversion (4, 12), so that Fe-S cluster forming or reforming enzymes may also be required for activity. The absence of these and MioC may be partly responsible for the very low catalytic center activity of the enzyme in the assay system with photo-reduced deazaflavin and highly purified biotin synthase (between 0.04 and 0.08/h, calculated from the results in Ref. 28).

The x-ray crystal structure of E. coli flavodoxin (Protein Data Bank file code 1ag9) shows that it crystallizes with two molecules in the asymmetric unit. Calcium, sodium, and chloride ions form salt bridges between the two molecules. Determination of the native molecular mass of MioC by gel filtration chromatography in low salt conditions showed MioC to be a dimer, but at relatively high salt concentrations (1.0 M NaCl) it behaved as a monomer, which is consistent with the disruption of intermolecular salt bridges.

During the original purification of MioC, where its activity in the biotin synthase reaction was measured, the addition of TPP to the buffers helped to maintain its activity. MioC has no TPP binding site, and following purification, TPP had no effect on its activity in the assay. We have no explanation for the positive effect of TPP during purification.

In conclusion, we have shown that MioC is required for biotin synthase activity in vitro. We suggest that MioC may have an electron transport role based on its predicted similarity to flavodoxin and its binding of FMN, and the fact that it can be replaced in the biotin synthase assay in vitro by photo-reduced deazaflavin. Despite inclusion of MioC in the biotin synthase assay, catalytic activity was still not observed. Unknown factors, such as Fe-S cluster forming enzymes, may have been missing. Further experiments are required to confirm the role of MioC in vivo and as part of a catalytic system for the formation of biotin.

    ACKNOWLEDGEMENTS

We thank Dr. R. T. Aplin for mass spectroscopy, Dr. M. Gross for CD analysis, and H. McNaughton for fluorescence spectroscopy.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by the Biotechnology and Biological Sciences Research Council and Lonza U.K.

** Recipient of a Royal Society University Research Fellowship.

Dagger Dagger To whom correspondence should be addressed. Tel.: 41-279-485937; Fax: 41-279-475937; E-mail: nicholas.shaw@lonzagroup.com.

Published, JBC Papers in Press, July 25, 2000, DOI 10.1074/jbc.M004497200

    ABBREVIATIONS

The abbreviations used are: Fe-S cluster, iron-sulfur cluster; TPP, thiamine pyrophosphate; PAGE, polyacrylamide gel electrophoresis; AE, activating enzyme; HPLC, high pressure liquid chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Flint, D. H., and Allen, R. M. (1997) Methods Enzymol. 279, 356-362
2. Shaw, N. M., Birch, O. M., Tinschert, A., Venetz, V., Dietrich, R., and Savoy, L.-A. (1998) Biochem. J. 330, 1079-1085
3. Sanyal, I., Gibson, K. J., and Flint, D. H. (1996) Arch. Biochem. Biophys. 326, 48-56
4. Tse Sum Bui, B., Florentin, D., Fournier, F., Ploux, O., Méjean, A., and Marquet, A. (1998) FEBS Lett. 440, 226-230
5. Ohshiro, T., Yamamoto, M., Izumi, Y., Tse Sum Bui, B., Florentin, D., and Marquet, A. (1994) Biosci. Biotechnol. Biochem. 58, 1738-1741
6. Birch, O. M., Brass, J. M., Fuhrmann, M., and Shaw N. M. (April 14, 1994) Patent Cooperation Treaty Patent Application WO 94/08023
7. Birch, O. M., Fuhrmann, M., and Shaw, N. M. (1995) J. Biol. Chem. 270, 19158-19165
8. McIver, L., Leadbeater, C., Campopiano, D. J., Baxter, R. L., Daff, S. N., Chapman, K., and Munro, A. W. (1998) Eur. J. Biochem. 257, 577-585
9. Ifuku, O., Koga, N., and Haze, S. (1994) Eur. J. Biochem. 224, 173-178
10. Guianvarc'h, D., Florentin, D., Tse Sum Bui, B., Nunzi, F., and Marquet, A. (1997) Biochem. Biophys. Res. Commun. 236, 402-406
11. Escalettes, F., Florentin, D., Tse Sum Bui, B., Lesage, D., and Marquet, A. (1999) J. Am. Chem. Soc. 121, 3571-3578
12. Gibson, K. J., Pelletier, D. A., and Turner, I. M., Sr. (1999) Biochem. Biophys. Res. Commun. 254, 632-635
13. Zheng, L., Cash, V. L., Flint, D. H., and Dean, D. R. (1998) J. Biol. Chem. 273, 13264-13272
14. Nakamura, M., Saeki, K., and Takahashi, Y. (1999) J. Biochem. (Tokyo) 126, 10-18
15. Takahashi, Y., and Nakamura, M. (1999) J. Biochem. (Tokyo) 126, 917-926
16. Osborne, C., Chen, L. M., and Matthews, R. G. (1991) J. Bacteriol. 173, 1729-1737
17. Hughes, G. J., Frutiger, S., Paquet, N., and Jaton, J.-C. (1990) Biochem. J. 271, 641-647
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
19. Burland, V., Plunkett, G., Daniels, D. L., and Blattner, F. R. (1993) Genomics 16, 551-561
20. Becker, A., Fritz-Wolf, K., Kabsch, W., Knappe, J., Schultz, S., and Wagner, A. F. V. (1999) Nat. Struct. Biol. 6, 969-975
21. Mulliez, E., Ollagnier, S., and Fontecave, M. (1999) in Iron Metabolism (Ferreira, G. C. , Moura, J. G. , and Franco, R., eds) , Wiley-VCH Verlag GmbH, Weinheim, Germany
22. Løbner-Oleson, A., Atlung, T., and Rasmussen, K. (1987) J. Bacteriol. 169, 2835-2842
23. Asai, T. (1991) Jpn. J. Genet. 66, 85-107
24. Ogawa, T., and Okazaki, T. (1994) J. Bacteriol. 176, 1609-1615
25. Løbner-Oleson, A., and Boye, E. (1992) Nucleic Acids Res. 20, 3029-3036
26. Bates, D. B., Boye, E., Asai, T., and Kogoma, T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12497-12502
27. Méjean, A., Tse Sum Bui, B., Florentin, D., Ploux, O., Izumi, Y., and Marquet, A. (1995) Biochem. Biophys. Res. Commun. 217, 1231-1237
28. Grandori, R., and Carey, J. (1994) Protein Sci. 3, 2185-2193


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Cotruvo Jr. and J. Stubbe
NrdI, a flavodoxin involved in maintenance of the diferric-tyrosyl radical cofactor in Escherichia coli class Ib ribonucleotide reductase
PNAS, September 23, 2008; 105(38): 14383 - 14388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hu, Y. Li, X. Zhang, X. Guo, B. Xia, and C. Jin
Solution Structures and Backbone Dynamics of a Flavodoxin MioC from Escherichia coli in both Apo- and Holo-forms: IMPLICATIONS FOR COFACTOR BINDING AND ELECTRON TRANSFER
J. Biol. Chem., November 17, 2006; 281(46): 35454 - 35466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Picciocchi, R. Douce, and C. Alban
The Plant Biotin Synthase Reaction: IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL MITOCHONDRIAL ACCESSORY PROTEIN COMPONENTS
J. Biol. Chem., June 27, 2003; 278(27): 24966 - 24975.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
A. Picciocchi, R. Douce, and C. Alban
Biochemical Characterization of the Arabidopsis Biotin Synthase Reaction. The Importance of Mitochondria in Biotin Synthesis
Plant Physiology, November 1, 2001; 127(3): 1224 - 1233.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/41/32277    most recent
M004497200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birch, O. M.
Right arrow Articles by Shaw, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birch, O. M.
Right arrow Articles by Shaw, N. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement